BLCM : Insider Transactions for Bellicum Pharmaceuticals, Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Bellicum Pharmaceuticals, Inc (BLCM)

$0.07 0.00 (0.00%) as of 4:30 Mon 3/4

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

6,100,000

Market Cap:

455.98(K)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0.0745 - $0.96

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing controllable cellular immunotherapies for the treatment of various forms of cancer. Co. is developing chimeric antigen receptors (CAR)-T cell therapies, which are an approach in which a patient's or donor's T cells are genetically modified to carry CARs. By incorporating its switch technologies, Co. is developing product candidates in various areas of cellular immunotherapy including BPX-601, which is designed to treat solid tumors expressing prostate stem cell antigen; and BPX-603, which is designed to target solid tumors that express the human epidermal growth factor receptor 2 antigen.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-01	2023-10-31	2023-05-02	2022-05-02

Adjust Filter Settings

Records found: 179

Page 5 of 8

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Spencer David M.

Chief Scientific Officer

• – –

2016-09-22

4

AS

$19.68

$196,832

D/D

(10,000)

162,282

-

Spencer David M.

Chief Scientific Officer

• – –

2016-09-21

4

AS

$20.04

$6,012

D/D

(300)

172,282

-

Sr. VP and General Counsel

• – –

2016-09-21

4

AS

$20.04

$2,004

D/D

(100)

344

-

Sr. VP and General Counsel

• – –

2016-09-21

4

OE

$7.47

$747

D/D

100

444

-

Slawin Kevin M.

Chief Technology Officer

• • –

2016-09-21

4

AS

$20.04

$2,004

I/I

(100)

366,940

-

Slawin Kevin M.

Chief Technology Officer

• • –

2016-09-21

4

AS

$20.04

$2,004

D/D

(100)

95,464

-

Spencer David M.

Chief Scientific Officer

• – –

2016-09-20

4

AS

$20.00

$2,000

D/D

(100)

172,582

-

Slawin Kevin M.

Chief Technology Officer

• • –

2016-09-20

4

AS

$20.00

$2,000

I/I

(100)

367,040

-

Slawin Kevin M.

Chief Technology Officer

• • –

2016-09-20

4

AS

$20.00

$6,000

D/D

(300)

95,564

-

Sr. VP and General Counsel

• – –

2016-09-20

4

AS

$20.00

$4,000

D/D

(200)

344

-

Sr. VP and General Counsel

• – –

2016-09-20

4

OE

$7.47

$1,494

D/D

200

544

-

Spencer David M.

Chief Scientific Officer

• – –

2016-09-19

4

AS

$20.02

$14,013

D/D

(700)

172,682

-

Slawin Kevin M.

Chief Technology Officer

• • –

2016-09-19

4

AS

$20.01

$24,129

I/I

(1,206)

367,140

-

Slawin Kevin M.

Chief Technology Officer

• • –

2016-09-19

4

AS

$20.02

$28,024

D/D

(1,400)

95,864

-

Sr. VP and General Counsel

• – –

2016-09-19

4

AS

$20.01

$26,018

D/D

(1,300)

344

-

Sr. VP and General Counsel

• – –

2016-09-19

4

OE

$7.47

$9,711

D/D

1,300

1,644

-

Spencer David M.

Chief Scientific Officer

• – –

2016-09-16

4

AS

$20.01

$34,015

D/D

(1,700)

173,382

-

Slawin Kevin M.

Chief Technology Officer

• • –

2016-09-16

4

AS

$20.00

$12,720

I/I

(636)

368,346

-

Slawin Kevin M.

Chief Technology Officer

• • –

2016-09-16

4

AS

$20.00

$18,840

D/D

(942)

97,264

-

Sr. VP and General Counsel

• – –

2016-09-16

4

AS

$20.00

$14,000

D/D

(700)

344

-

Sr. VP and General Counsel

• – –

2016-09-16

4

OE

$7.47

$5,229

D/D

700

1,044

-

Slawin Kevin M.

Chief Technology Officer

• • –

2016-08-15

4

AS

$19.27

$598,931

I/I

(31,000)

368,982

-

Slawin Kevin M.

Chief Technology Officer

• • –

2016-08-15

4

AS

$19.27

$695,012

D/D

(36,000)

98,206

-

Spencer David M.

Chief Scientific Officer

• – –

2016-08-15

4

AS

$20.00

$20,000

D/D

(1,000)

175,082

-

Sr. VP and General Counsel

• – –

2016-08-15

4

AS

$20.00

$20,000

D/D

(1,000)

344

-

179 Records found	1 2 3 4 5 6 7 8	Page 5 of 8

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.